尊龙凯时人生就是搏·(中国区)官方网站

NOTIFICATION OF BOARD MEETING

VOLUNTARY ANNOUNCEMENT - BEVACIZUMAB INJECTION APPROVED FOR MARKETING

VOLUNTARY ANNOUNCEMENT - THREE PRODUCTS APPROVED FOR MARKETING

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 28 FEBRUARY 2023

NEXT DAY DISCLOSURE RETURN

NEXT DAY DISCLOSURE RETURN

NEXT DAY DISCLOSURE RETURN

VOLUNTARY ANNOUNCEMENT - APPROVAL OF “LIMAPROST TABLETS” FOR MARKETING